BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 37770919)

  • 1. Network module analysis and molecular docking-based study on the mechanism of astragali radix against non-small cell lung cancer.
    Xiao W; Xu Y; Baak JP; Dai J; Jing L; Zhu H; Gan Y; Zheng S
    BMC Complement Med Ther; 2023 Sep; 23(1):345. PubMed ID: 37770919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the mechanism of aidi injection for lung cancer by network pharmacology approach and molecular docking validation.
    Zhuang Z; Lin T; Luo L; Zhou W; Wen J; Huang H; Liu Z; Lin L
    Biosci Rep; 2021 Feb; 41(2):. PubMed ID: 33506873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elucidating the mechanism of action of Isobavachalcone induced autophagy and apoptosis in non-small cell lung cancer by network pharmacology and experimental validation methods.
    Wang L; Wang Z; Ni Y; Wang X; Zhang T; Hu M; Lian C; Wang X; Zhang J
    Gene; 2024 Aug; 918():148474. PubMed ID: 38670393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mechanism of Bai He Gu Jin Tang against non-small cell lung cancer revealed by network pharmacology and molecular docking.
    Xie RF; Song ZY; Xu-Shao LY; Huang JG; Zhao T; Yang Z
    Medicine (Baltimore); 2022 Dec; 101(52):e32555. PubMed ID: 36596057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanism of n-butanol fraction of Wenxia Formula combining with gefitinib in treating non-small cell lung cancer based on network pharmacology and in vitro experiment].
    Chen RJ; Bi QY; Shi JM; Zhong J; Han JT; Ji XM
    Zhongguo Zhong Yao Za Zhi; 2024 Jan; 49(2):471-486. PubMed ID: 38403323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of
    Wang Q; Zhen W; Lippi G; Liu Q
    Transl Androl Urol; 2024 Jan; 13(1):91-103. PubMed ID: 38404557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism exploration and prognosis study of Astragali Radix-Spreading hedyotis herb for the treatment of lung adenocarcinoma based on bioinformatics approaches and molecular dynamics simulation.
    Guo J; Zhao Y; Wu X; Li G; Zhang Y; Song Y; Du Q
    Front Chem; 2023; 11():1128671. PubMed ID: 37065830
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular mechanism of Rhubarb in the treatment of non-small cell lung cancer based on network pharmacology and molecular docking technology.
    Tan YR; Lu Y
    Mol Divers; 2023 Jun; 27(3):1437-1457. PubMed ID: 35933455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated bioinformatics and network pharmacology to explore the therapeutic target and molecular mechanisms of Taxus chinensis against non-small cell lung cancer.
    Zhang S; Wang J; Zhang H
    Medicine (Baltimore); 2023 Nov; 102(44):e35826. PubMed ID: 37933017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discussion on the molecular mechanism of Duhuo Jisheng decoction in treating osteoarthritis based on network pharmacology and molecular docking.
    Yang L; Zheng S; Hou A; Wang S; Zhang J; Yu H; Wang X; Lan W
    Medicine (Baltimore); 2022 Oct; 101(42):e31009. PubMed ID: 36281111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration of Network Pharmacology and Molecular Docking Technology Reveals the Mechanism of the Therapeutic Effect of Xixin Decoction on Alzheimer's Disease.
    Zhang Z; Xu J; Ma S; Lin N; Hou M; Wei M; Li T; Shi J
    Comb Chem High Throughput Screen; 2022; 25(10):1785-1804. PubMed ID: 35616676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the Active Compounds and Significant Pathways of Artemisia Annua in the Treatment of Non-Small Cell Lung Carcinoma based on Network Pharmacology.
    Zhang SQ; Xu HB; Zhang SJ; Li XY
    Med Sci Monit; 2020 May; 26():e923624. PubMed ID: 32474568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the mechanism of Astragali radix for promoting osteogenic differentiation based on network pharmacology, molecular docking, and experimental validation.
    Tian Z; Li Y; Wang X; Cui K; Guo J; Wang M; Hao Y; Zhang F
    Chem Biol Drug Des; 2023 Dec; 102(6):1489-1505. PubMed ID: 37690812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using Network Pharmacology and Molecular Docking to Explore the Mechanism of Shan Ci Gu (
    Wang Y; Zhang Y; Wang Y; Shu X; Lu C; Shao S; Liu X; Yang C; Luo J; Du Q
    Front Chem; 2021; 9():682862. PubMed ID: 34178945
    [No Abstract]   [Full Text] [Related]  

  • 15. Network Pharmacology Combined with Bioinformatics to Investigate the Mechanisms and Molecular Targets of
    Zhao J; Mo C; Shi W; Meng L; Ai J
    Evid Based Complement Alternat Med; 2021; 2021():9980981. PubMed ID: 34349833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on mechanism of Rehmanniae Radix Praeparata for treatment of osteoarthritis based on network pharmacology and molecular docking].
    Feng WQ; Liu KY; Zhang JN; Li YZ; Liu JL; Lu JQ; Zhang YL
    Zhongguo Zhong Yao Za Zhi; 2022 Oct; 47(19):5336-5343. PubMed ID: 36472041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating the efficacy and mechanisms of Jinfu'an decoction in treating non-small cell lung cancer using network pharmacology and in vitro and in vivo experiments.
    Peng H; Huang Z; Li P; Sun Z; Hou X; Li Z; Sang R; Guo Z; Wu S; Cao Y
    J Ethnopharmacol; 2024 Mar; 321():117518. PubMed ID: 38042385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Network pharmacology and experimental verification based research into the effect and mechanism of Aucklandiae Radix-Amomi Fructus against gastric cancer.
    Song S; Zhou J; Li Y; Liu J; Li J; Shu P
    Sci Rep; 2022 Jun; 12(1):9401. PubMed ID: 35672352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of "Hedyotis Diffusae Herba-Smilacis Glabrae Rhizoma" in treatment of lung adenocarcinoma based on network pharmacology].
    Li JL; Hou W
    Zhongguo Zhong Yao Za Zhi; 2021 Dec; 46(23):6261-6270. PubMed ID: 34951253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A real-world study and network pharmacology analysis of EGFR-TKIs combined with ZLJT to delay drug resistance in advanced lung adenocarcinoma.
    Han X; Liang L; He C; Ren Q; Su J; Cao L; Zheng J
    BMC Complement Med Ther; 2023 Nov; 23(1):422. PubMed ID: 37990309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.